Aurobindo Pharma Limited (AUROPHARMA.BO)
INR 1264.95
(1.37%)
INR 1264.95
(1.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 98.08 Billion INR | 15.24% |
| 2022 | 85.11 Billion INR | 12.67% |
| 2021 | 75.53 Billion INR | -16.32% |
| 2020 | 90.26 Billion INR | 17.23% |
| 2019 | 76.99 Billion INR | 6.27% |
| 2018 | 72.45 Billion INR | 23.68% |
| 2017 | 58.58 Billion INR | 35.28% |
| 2016 | 43.3 Billion INR | 6.77% |
| 2015 | 40.56 Billion INR | 12.68% |
| 2014 | 35.99 Billion INR | 52.04% |
| 2013 | 23.67 Billion INR | 23.08% |
| 2012 | 19.23 Billion INR | 24.46% |
| 2011 | 15.45 Billion INR | 6.2% |
| 2010 | 14.55 Billion INR | 32.0% |
| 2009 | 11.02 Billion INR | 25.62% |
| 2008 | 8.77 Billion INR | 10.39% |
| 2007 | 7.95 Billion INR | 21.49% |
| 2006 | 6.54 Billion INR | 38.7% |
| 2005 | 4.71 Billion INR | 25.66% |
| 2004 | 3.75 Billion INR | 17.56% |
| 2003 | 3.19 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 92.82 Billion INR | 0.0% |
| 2023 Q4 | 98.08 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 98.08 Billion INR | 15.24% |
| 2022 FY | 85.11 Billion INR | 12.67% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 78.9 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 85.11 Billion INR | 0.0% |
| 2021 Q4 | 75.53 Billion INR | 0.0% |
| 2021 FY | 75.53 Billion INR | -16.32% |
| 2021 Q2 | 84.68 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 90.26 Billion INR | 0.0% |
| 2020 FY | 90.26 Billion INR | 17.23% |
| 2020 Q2 | 88.23 Billion INR | 0.0% |
| 2019 Q2 | 75.92 Billion INR | 0.0% |
| 2019 FY | 76.99 Billion INR | 6.27% |
| 2019 Q4 | 76.99 Billion INR | 0.0% |
| 2018 FY | 72.45 Billion INR | 23.68% |
| 2018 Q2 | 68.17 Billion INR | 0.0% |
| 2018 Q4 | 72.45 Billion INR | 0.0% |
| 2017 Q4 | 58.58 Billion INR | 0.0% |
| 2017 FY | 58.58 Billion INR | 35.28% |
| 2017 Q2 | 51.89 Billion INR | 0.0% |
| 2016 FY | 43.3 Billion INR | 6.77% |
| 2016 Q2 | 42.01 Billion INR | 0.0% |
| 2016 Q4 | 43.3 Billion INR | 0.0% |
| 2015 Q2 | 40.86 Billion INR | 0.0% |
| 2015 Q4 | 40.56 Billion INR | 0.0% |
| 2015 FY | 40.56 Billion INR | 12.68% |
| 2014 Q2 | 35.19 Billion INR | 0.0% |
| 2014 Q4 | 35.99 Billion INR | 0.0% |
| 2014 FY | 35.99 Billion INR | 52.04% |
| 2013 Q2 | 21.18 Billion INR | 0.0% |
| 2013 Q4 | 23.67 Billion INR | 0.0% |
| 2013 FY | 23.67 Billion INR | 23.08% |
| 2012 Q4 | 19.23 Billion INR | 0.0% |
| 2012 FY | 19.23 Billion INR | 24.46% |
| 2011 Q4 | 15.45 Billion INR | 0.0% |
| 2011 FY | 15.45 Billion INR | 6.2% |
| 2010 FY | 14.55 Billion INR | 32.0% |
| 2009 FY | 11.02 Billion INR | 25.62% |
| 2008 FY | 8.77 Billion INR | 10.39% |
| 2007 FY | 7.95 Billion INR | 21.49% |
| 2006 FY | 6.54 Billion INR | 38.7% |
| 2005 FY | 4.71 Billion INR | 25.66% |
| 2004 FY | 3.75 Billion INR | 17.56% |
| 2003 FY | 3.19 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | -1084.054% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -33832.994% |
| Sigachi Industries Limited | 707.2 Million INR | -13768.966% |
| Bal Pharma Limited | 878.11 Million INR | -11069.655% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -93689.552% |
| Medico Remedies Limited | 163.37 Million INR | -59936.175% |
| Lasa Supergenerics Limited | 190.43 Million INR | -51404.616% |
| Venus Remedies Limited | 1.21 Billion INR | -7960.013% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -71674.714% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -1283.094% |
| Shilpa Medicare Limited | 3.44 Billion INR | -2743.558% |
| Aarti Drugs Limited | 4.85 Billion INR | -1918.611% |
| Lupin Limited | 49.53 Billion INR | -97.99% |
| Zydus Lifesciences Limited | 34.41 Billion INR | -184.966% |
| Windlas Biotech Limited | 621.89 Million INR | -15671.648% |
| Suven Life Sciences Limited | 7.08 Million INR | -1384265.561% |
| Eris Lifesciences Limited | 1.89 Billion INR | -5088.661% |
| Valiant Laboratories Limited | 100.15 Million INR | -97831.486% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -1851.848% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -2626.781% |
| Ipca Laboratories Limited | 24.71 Billion INR | -296.884% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -8180.67% |
| Achyut Healthcare Limited | 568 Thousand INR | -17267910.563% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 0.609% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -6709.464% |
| RPG Life Sciences Limited | 1.01 Billion INR | -9611.119% |
| Mankind Pharma Limited | 15.53 Billion INR | -531.379% |
| Laurus Labs Limited | 18.45 Billion INR | -431.493% |
| Piramal Pharma Limited | 21.75 Billion INR | -350.771% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -46425.295% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -330.374% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -496.775% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | -290.292% |
| Unichem Laboratories Limited | 7.04 Billion INR | -1291.878% |
| Sequent Scientific Limited | 3.46 Billion INR | -2732.849% |
| Novartis India Limited | 448.6 Million INR | -21764.088% |
| Wanbury Limited | 360.23 Million INR | -27127.537% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -4142.393% |
| Wockhardt Limited | 6.4 Billion INR | -1432.536% |
| Themis Medicare Limited | 705.74 Million INR | -13797.736% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -65301.28% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -660.564% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -1371.402% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | -54.334% |
| Divi's Laboratories Limited | 31.84 Billion INR | -208.047% |
| NATCO Pharma Limited | 7 Billion INR | -1300.176% |
| Gufic Biosciences Limited | 2 Billion INR | -4792.322% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -2208.688% |
| Ind-Swift Limited | 640.91 Million INR | -15203.48% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -8889.304% |
| FDC Limited | 3.88 Billion INR | -2422.118% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -100020.759% |
| Granules India Limited | 13 Billion INR | -654.163% |
| Medicamen Biotech Limited | 593.75 Million INR | -16419.069% |
| Alkem Laboratories Limited | 26.61 Billion INR | -268.567% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -4204.083% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -384581.727% |
| Brooks Laboratories Limited | 96.1 Million INR | -101954.251% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -11969.751% |
| Strides Pharma Science Limited | 11.26 Billion INR | -770.883% |
| Neuland Laboratories Limited | 3.5 Billion INR | -2698.977% |
| Morepen Laboratories Limited | 2.48 Billion INR | -3845.478% |
| Hikal Limited | 3.03 Billion INR | -3129.366% |
| Indoco Remedies Limited | 3.53 Billion INR | -2678.063% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -1425.718% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -245843.581% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -7832.907% |
| Hester Biosciences Limited | 755.81 Million INR | -12877.111% |